Using Clinical And Economic Evidence To Infrom Local Decision Making In Cancer Care
Funder
National Health and Medical Research Council
Funding Amount
$1,836,745.00
Summary
Medicines used to treat cancer often come with a high price tag. Many countries, including Australia, are no longer able to provide free access to all medicines. For this reason, patients and their families, public hospitals and private health insurers are often asked to pay for these treatments. Currently, health professionals and patients are ill-equipped to make informed treatment choices, since both cost and efficacy must be considered. Our proposed research will address this important gap i ....Medicines used to treat cancer often come with a high price tag. Many countries, including Australia, are no longer able to provide free access to all medicines. For this reason, patients and their families, public hospitals and private health insurers are often asked to pay for these treatments. Currently, health professionals and patients are ill-equipped to make informed treatment choices, since both cost and efficacy must be considered. Our proposed research will address this important gap in current knowledge. We will use a unique web-based resource (Cancer Institute NSW Standard Cancer Treatment Program; CI-SCaT) to communicate the economic evidence needed to make informed decisions about cancer treatments. Our project will provide public access to information about the effectiveness and costs of cancer drugs. This is a world first. CI-SCaT is already the main vehicle of communication about cancer drug treatments in NSW and is widely used by cancer health professionals and patients to inform point-of-care decisions. Our project we will also identify the factors which influence the ability of cancer treatment centres to make best use of their drug budgets. By achieving this goal, we hope to demonstrate how to best use scarce resources for the benefit of all cancer patients.Read moreRead less
The Diamond Cohort Study - Long Term Outcomes Of Depressive Symptoms In Primary Care
Funder
National Health and Medical Research Council
Funding Amount
$567,538.00
Summary
The diamond study follows what happens to almost 800 people with depressive symptoms whom attend general practice for care over 5 years of their life. This study will map the severity of depressive symptoms, life circumstances, use of health care services and treatments and allow us to understand factors associated with relapse and recovery from depression in order to improve care. This will assist us to develop models of care that better suit the needs of people experiencing depressive symptoms ....The diamond study follows what happens to almost 800 people with depressive symptoms whom attend general practice for care over 5 years of their life. This study will map the severity of depressive symptoms, life circumstances, use of health care services and treatments and allow us to understand factors associated with relapse and recovery from depression in order to improve care. This will assist us to develop models of care that better suit the needs of people experiencing depressive symptoms.Read moreRead less
Investigating Best Practice Primary Care For Older Australians With Diabetes Using Data Linkage
Funder
National Health and Medical Research Council
Funding Amount
$522,278.00
Summary
This study will use data linkage to examine questions about health service use by older Australians to manage chronic conditions such as diabetes. It will lead to a better understanding of the uptake of community based care initiatives and incentives through general practice, the factors that assist or impede uptake, and the impact of these on patient outcomes such as hospitalisation. The research findings will address important questions of interest to practitioners and policy advisors.
Consumer Directed Care In Residential Aged Care: Transforming Practice Through The Resident At The Centre Of Care (RCC) Program
Funder
National Health and Medical Research Council
Funding Amount
$836,087.00
Summary
The impending introduction of Consumer Directed Care (CDC) into Residential Aged Care Facilities (RACFs) will require organisations to respond rapidly in both ‘mindset’ and service delivery to radically change the nature of their current care practices. This project will allow our industry partners to implement and evaluate a CDC model of care that, if successful, will lead to a sustainable site specific implementation plan of CDC for RACFs across Australia with better outcomes for residents.
Defining And Optimising The Economic And Social Return On Investment Of Telephone Cancer Information And Support Services For All Australians
Funder
National Health and Medical Research Council
Funding Amount
$936,787.00
Summary
The economic and social value of telephone cancer information and support services (CISS) for Australia is undefined thus hindering decisions about the future direction of services and levels of funding. This research will identify and compare the broad monetised, social benefits of CISS with the costs of providing the service. We will identify different strategies to deliver, promote and target services to improve cancer outcomes for all Australians and maximise the return on investment.
Towards Evidence-based Adoption And Scale-up Of Cost-saving Primary Health Care Innovations
Funder
National Health and Medical Research Council
Funding Amount
$408,768.00
Summary
What innovations like service integration, care coordination and information technology (e.g. text message reminders, remote video consultations, remote monitoring) have in common is that they alter the patient-provider interface, more reliably and consistently than improving clinical outcomes. So, to determine their true costs and benefits, how to select among them and how to scale them up, this research program will assess them based on measures of how they alter patient-provider transactions.
MSDI Evidence Review Service (ERS) will connect leaders to the best-available knowledge when they need it. It consists of a specialist team of review scientists with a track record of projects with ‘real world’ relevance and impact.